Skip to content
DataLookout
Menu

NCT02278744

Trial for Salvage Re-Irradiation of Metastatic Spine Lesions Using Single-Fraction Stereotactic Radiosurgery

StatusActive, Not Recruiting
PhasePhase 1
Primary completion (estimated)

At risk: Primary completion moved at least 11 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 20 versions: 16 with changes below, 4 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Oct 2026 to Oct 2027
    • Eligibility criteria expanded, about 8 words
    • Interventions: MRI and/or CT (Device), single-fraction radiation (Radiation) to MRI and/or CT (Device), single-fraction radiation (Radiation)
    • Secondary endpoints: details revised at 2 of 2 entries
  2. Notable Primary and study completion dates: Oct 2025 to Oct 2026v19
  3. Notable Primary and study completion dates: Oct 2024 to Oct 2025v17
  4. Notable Primary and study completion dates: Oct 2023 to Oct 2024v16
  5. Notable Primary and study completion dates: Oct 2022 to Oct 2023v15
Show 10 earlier versionsHide 10 earlier versions
  1. Minor Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 18 to confirmed 9
    • Start date: Oct 2014 to Oct 27, 2014
    • Site details revised
    v13
  2. Notable Primary and study completion dates: Oct 2021 to Oct 2022v12
  3. Notable Primary and study completion dates: Oct 2019 to Oct 2021v10
  4. Notable Primary and study completion dates: Oct 2018 to Oct 2019v9
  5. Notable Primary completion date: Oct 2017 to Oct 2018
    • Study completion date: Oct 2018
    v8
  6. Notable Eligibility criteria shortened, about 52 wordsv6
  7. Notable Eligibility criteria expanded, about 14 words
    • Interventions: MRI or CT (Device), single-fraction radiation (Radiation) to MRI and/or CT (Device), single-fraction radiation (Radiation)
    v5
  8. Notable Primary completion date: Oct 2016 to Oct 2017v4
  9. Notable Eligibility criteria expanded, about 2 words
    • Interventions: MRI (Device), single-fraction radiation (Radiation) to MRI or CT (Device), single-fraction radiation (Radiation)
    v3
  10. Notable Eligibility criteria expanded, about 28 wordsv2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

toxicities as measured by the National Cancer Institute (NCI) Common Toxicity Criteria
Timeframe: 1 year

Secondary (2)

local failure
overall survival

Arms and interventions

single-fraction radiosurgeryExperimental

Radiation: single-fraction radiation

Devices: MRI and/or CT

Sites

1 site in 1 country

  • Memorial Sloan Kettering Cancer CenterNew York, New York, United States